Skip to main content

Day: August 3, 2020

vTv Therapeutics Announces 2020 Second Quarter Financial Results and Update

HIGH POINT, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the second quarter ended June 30, 2020, and provided an update on the progress of its clinical programs.“Building on the successful phase 2 study completed earlier this year with TTP399, we have been highly focused on advancing this promising candidate as an adjunct to insulin for type 1 diabetes into the next stage of clinical development,” said Steve Holcombe, president and CEO. “To this end, we have been engaging with the FDA to determine the development path for TTP399 and are in the planning stages for our first pivotal study, which we anticipate commencing by the end of 2020.  We have also continued to enroll patients in our phase 2 study of azeliragon for the treatment of Alzheimer’s disease in patients...

Continue reading

Green Plains Reports Second Quarter 2020 Financial Results

Results for the Second Quarter of 2020:Net loss attributable to the company of $8.2 million, or $(0.24) per diluted shareAdjusted EBITDA of $17.9 millionCash, cash equivalents and restricted cash of $183.6 million; $289.0 million available under working capital facilitiesIndustrial high-quality alcohol sales positively impacted the quarterGreen Plains Cattle Company achieved record resultsAnnounced USP grade alcohol upgrades for Green Plains York LLC and Green Plains Wood River LLCSecured a $75 million project based financing line, which is expected to close during the third quarter to support high protein production expansion and announced Green Plains Wood River LLC’s high protein projectGreen Plains Partners refinancing of debt facility completedOMAHA, Neb., Aug. 03, 2020 (GLOBE NEWSWIRE) — Green Plains Inc. (NASDAQ:GPRE) today...

Continue reading

HighPoint Resources Reports Second Quarter 2020 Financial and Operating Results

Reported production sales volume of 2.9 million barrels of oil equivalent (“MMBoe”) for the second quarter of 2020, exceeding the high end of guidance by 12% driven by well performance, timing of completions and minimal downtime          Oil production sales volume of 1.6 million barrels of oil (“MMBbls”) for the second quarter of 2020; 57% of total equivalent production sales volume exceeding the high end of guidance by 11% Second quarter of 2020 capital expenditures of $25 million were 38% below guidance Second quarter of 2020 controllable operating costs1 were $9.13 per Boe. Excluding non-recurring severance and other costs of $1.36 per Boe, controllable operating costs were 12% lower than the first quarter of 2020 High fluid intensity completions continue to positively impact well performance at Hereford and...

Continue reading

Sensata Technologies Holding plc Announces Pricing of $750 Million of Senior Notes by Sensata Technologies, Inc.

SWINDON, United Kingdom, Aug. 03, 2020 (GLOBE NEWSWIRE) — Sensata Technologies Holding plc (NYSE: ST) (“Sensata Technologies”) today announced that its indirect wholly owned subsidiary, Sensata Technologies, Inc. (the “Issuer”), priced $750 million in aggregate principal amount of 3.750% senior notes due 2031 (the “Notes”) in a private offering that is exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). The Notes were priced at par. The closing of the offering is expected to occur on August 17, 2020, subject to customary closing conditions. The Notes will be guaranteed on a senior unsecured basis by Sensata Technologies B.V., the Issuer’s indirect parent (“STBV”), and each of STBV’s wholly owned subsidiaries (other than the Issuer) that is a guarantor under Sensata’s senior credit facilities...

Continue reading

Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors

NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Royalty Pharma (Nasdaq: RPRX) today announced the appointments of Henry A. Fernandez and Ted W. Love, M.D. to the company’s Board of Directors, effective immediately. Mr. Fernandez is Chairman and Chief Executive Officer of MSCI Inc., a leading global provider of investment decision support tools. Dr. Love is President and Chief Executive Officer of Global Blood Therapeutics, a biopharmaceutical company focused on the treatment and care of sickle cell disease.“Following our successful initial public offering, we are further strengthening the governance of Royalty Pharma with the appointments to the Board of Henry Fernandez and Ted Love,” said Pablo Legorreta, Founder and CEO of Royalty Pharma. “Both are highly entrepreneurial and bring exceptional leadership qualities achieved...

Continue reading

Regency Centers Reports Second Quarter 2020 Results and Provides Business Update Related to COVID-19

JACKSONVILLE, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency” or the “Company”) today reported financial and operating results for the period ended June 30, 2020, and provided a  business update related to COVID-19.Second Quarter 2020 HighlightsFor the three months ended June 30, 2020, Net Income Attributable to Common Stockholders (“Net Income”) of $0.11 per diluted share.For the three months ended June 30, 2020, NAREIT Funds From Operations (“NAREIT FFO”) of $0.61 per diluted share.Same property Net Operating Income (“NOI”), excluding termination fees, declined by 20.1%, as compared to the three months ended June 30, 2019, driven by a higher rate of uncollectible lease income related to the COVID-19 pandemic.  As of June 30, 2020, the same property portfolio was 94.5% leased.Completed a public offering...

Continue reading

Fluent, Inc. to Announce Second Quarter 2020 Financial Results on August 10, 2020

NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leading data-driven performance marketing company, announced today that it will report its financial results for the second quarter ended June 30, 2020 after the close of the U.S. financial markets on Monday, August 10, 2020.The Company will host a conference call on August 10, 2020 at 4:30pm ET to discuss its quarterly results and provide a business update. The conference call information is listed below. The call will also be webcast simultaneously on the Fluent website at www.fluentco.com. Please login at least 15 minutes prior to the start of the call to ensure adequate time for any downloads that may be required.CONFERENCE CALL & WEBCAST INFORMATIONWHEN: Monday, August 10, 2020 at 4:30pm ETDOMESTIC DIAL-IN: (888) 339-0797INTERNATIONAL DIAL-IN: (412)...

Continue reading

Atlas Technical Consultants Announces Agreement to Acquire Alta Vista

AUSTIN, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading provider of professional testing, inspection, engineering, program management and consulting services, announced today that it has entered into a definitive agreement to acquire Alta Vista Solutions, Inc. (“Alta Vista”), a key provider of transportation-related testing and inspection services, headquartered in Oakland, California. Alta Vista has approximately 100 employees, operating out of four offices in California and one office in New York City, bringing a broad array of construction engineering, materials testing, inspection, quality management, asset management and infrastructure services.L. Joe Boyer, Atlas’ Chief Executive Officer, said, “Alta Vista’s transportation focus, wide range of services...

Continue reading

Sykes Enterprises, Incorporated Issues Notice of Release for Second-Quarter 2020 Financial Results

TAMPA, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) — Sykes Enterprises, Incorporated (“SYKES” or the “Company”) (NASDAQ: SYKE), a leading full life cycle provider of global customer engagement services, multichannel demand generation and digital transformation, has released its financial results for the second-quarter ended June 30, 2020. The second-quarter 2020 financial results can be viewed at either www.sykes.com, under the “Investor News” section, or using the following link: http://investor.sykes.com/company/investors/investor-news/default.aspx.Forward-Looking StatementsThis press release may contain “forward-looking statements,” including SYKES’ estimates of its future business outlook, prospects or financial results. Statements regarding SYKES’ objectives, expectations, intentions, beliefs or strategies, or statements...

Continue reading

Star Group, L.P. Reports Fiscal 2020 Third Quarter Results

STAMFORD, Conn., Aug. 03, 2020 (GLOBE NEWSWIRE) — Star Group, L.P. (the “Company” or “Star”) (NYSE:SGU), a home energy distributor and services provider, today announced financial results for the fiscal 2020 third quarter and nine months ended June 30, 2020.Three Months Ended June 30, 2020 Compared to the Three Months Ended June 30, 2019For the fiscal 2020 third quarter, Star reported an 18.1 percent decrease in total revenue to $232.2 million compared with $283.4 million in the prior-year period, as a decline in selling prices, in response to lower wholesale product costs, and reduced service and installation sales was only partially offset by an increase in home heating oil and propane volume sold.The volume of home heating oil and propane sold during the fiscal 2020 third quarter increased by 14.3 million...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.